Literature DB >> 30198014

Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer?

Yukiyoshi Hirayama1, Marianne D Sadar1.   

Abstract

Entities:  

Year:  2018        PMID： 30198014      PMCID： PMC6124673          DOI： 10.21037/amj.2018.06.02

Source DB:  PubMed          Journal:  AME Med J        ISSN： 2520-0518


× No keyword cloud information.
  14 in total

1.  Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5'-flanking region.

Authors:  Omar A Itani; Kang Z Liu; Kristyn L Cornish; Jason R Campbell; Christie P Thomas
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11       Impact factor: 4.310

2.  Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity.

Authors:  S y Chen; J Wang; G q Yu; W Liu; D Pearce
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

3.  The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors.

Authors:  Ning Xie; Helen Cheng; Dong Lin; Liangliang Liu; Ou Yang; Li Jia; Ladan Fazli; Martin E Gleave; Yuzhuo Wang; Paul Rennie; Xuesen Dong
Journal:  Int J Cancer       Date:  2014-08-27       Impact factor: 7.396

4.  Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer.

Authors:  O Sartor; M Weinberger; A Moore; A Li; W D Figg
Journal:  Urology       Date:  1998-08       Impact factor: 2.649

Review 5.  Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer.

Authors:  Philip A Watson; Vivek K Arora; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2015-11-13       Impact factor: 60.716

6.  Cell- and gene-specific regulation of primary target genes by the androgen receptor.

Authors:  Eric C Bolton; Alex Y So; Christina Chaivorapol; Christopher M Haqq; Hao Li; Keith R Yamamoto
Journal:  Genes Dev       Date:  2007-08-15       Impact factor: 11.361

7.  A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.

Authors:  Mary-Ellen Taplin; Judith Manola; William K Oh; Philip W Kantoff; Glenn J Bubley; Matthew Smith; Diana Barb; Christos Mantzoros; Edward P Gelmann; Steven P Balk
Journal:  BJU Int       Date:  2008-05       Impact factor: 5.588

8.  Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.

Authors:  Vivek K Arora; Emily Schenkein; Rajmohan Murali; Sumit K Subudhi; John Wongvipat; Minna D Balbas; Neel Shah; Ling Cai; Eleni Efstathiou; Chris Logothetis; Deyou Zheng; Charles L Sawyers
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

9.  A randomised phase 2 trial of dexamethasone versus prednisolone in castration-resistant prostate cancer.

Authors:  Ramachandran Venkitaraman; David Lorente; Vedang Murthy; Karen Thomas; Lydia Parker; Ruth Ahiabor; David Dearnaley; Robert Huddart; Johann De Bono; Chris Parker
Journal:  Eur Urol       Date:  2014-10-16       Impact factor: 20.096

10.  Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.

Authors:  Zhenfei Li; Andrew C Bishop; Mohammad Alyamani; Jorge A Garcia; Robert Dreicer; Dustin Bunch; Jiayan Liu; Sunil K Upadhyay; Richard J Auchus; Nima Sharifi
Journal:  Nature       Date:  2015-06-01       Impact factor: 49.962
View more
  5 in total

Review 1.  Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?

Authors:  Norman J Maitland
Journal:  Cancers (Basel)       Date:  2021-01-17       Impact factor: 6.639

2.  Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor.

Authors:  Chih-Shou Chen; Guan-Lun Gao; Dong-Ru Ho; Chih-Yi Lin; Yu-Ting Chou; Shan-Chun Chen; Min-Cong Huang; Wen-Ya Kao; Jyan-Gwo Joseph Su
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

Review 3.  Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer.

Authors:  Yifeng Mao; Gaowei Yang; Yingbang Li; Guowu Liang; Wangwang Xu; Mingqiu Hu
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

Review 4.  Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo.

Authors:  Amani Yehya; Fatima Ghamlouche; Amin Zahwe; Yousef Zeid; Kevork Wakimian; Deborah Mukherji; Wassim Abou-Kheir
Journal:  Cancer Drug Resist       Date:  2022-06-22

5.  Development of a High-Throughput Screening Assay for Small-Molecule Inhibitors of Androgen Receptor Splice Variants.

Authors:  Amy E Monaghan; Alison Porter; Irene Hunter; Angus Morrison; Stuart P McElroy; Iain J McEwan
Journal:  Assay Drug Dev Technol       Date:  2022-03-23       Impact factor: 2.471
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.